OS | PFS | |||||
---|---|---|---|---|---|---|
HR | (95%CI) | P | HR | (95%CI) | P | |
Age | ||||||
≤ 50 vs > 50 | 0.988 | 0.63–1.56 | 0.96 | 1.14 | 0.74–1.75 | 0.54 |
FIGO stage | ||||||
I–II vs III–IV | 0.890 | 1.14–5.33 | 0.01 | 1.12 | 1.22–6.65 | 0.04 |
Grade | ||||||
G1–2 vs G3 | 0.992 | 0.60–1.63 | 0.97 | 0.78 | 0.49–1.23 | 0.29 |
Tumor residual size | ||||||
0 cm vs ≤ 1 cm vs > 1 cm | 0.189 | 0.09–0.36 | 0.00 | 0.24 | 0.14–0.41 | 0.00 |
Tumor size | ||||||
≤ 10 cm vs > 10 cm | 1.564 | 0.78–1.56 | 0.57 | 0.89 | 0.89–2.86 | 0.67 |
hMSH2 expression | ||||||
Low vs high | 1.916 | 1.85–2.31 | 0.03 | 1.43 | 0.92–2.20 | 0.11 |